Sinew Pharma Inc. (TPEX:6634)
Taiwan · Delayed Price · Currency is TWD 48.80
-1.30 (-2.59%)
Sep 4, 2025, 1:56 PM CST
Sinew Pharma Market Cap
Sinew Pharma has a market cap or net worth of 3.49 billion as of September 4, 2025. Its market cap has decreased by -26.79% in one year.
Market Cap
3.49B
Enterprise Value
2.41B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
48.80
Market Cap Chart
Since June 29, 2017, Sinew Pharma's market cap has increased from 1.90B to 3.49B, an increase of 83.65%. That is a compound annual growth rate of 7.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 3.49B | 2.92% |
| Dec 31, 2024 | 3.39B | -29.30% |
| Dec 29, 2023 | 4.80B | -34.51% |
| Dec 30, 2022 | 7.33B | 29.47% |
| Dec 30, 2021 | 5.66B | 19.05% |
| Dec 31, 2020 | 4.75B | 392.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 326.49B |
| PharmaEssentia | 165.47B |
| Bora Pharmaceuticals Co., LTD. | 88.98B |
| Lotus Pharmaceutical | 49.44B |
| Oneness Biotech | 34.15B |
| Lumosa Therapeutics | 32.18B |
| Polaris Group | 30.09B |
| Center Laboratories | 26.72B |